These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36620161)

  • 1. Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy.
    Wang F; Xu X; Wang Q; Yu D; Lv L; Wang Q
    Quant Imaging Med Surg; 2023 Jan; 13(1):449-461. PubMed ID: 36620161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy.
    Wang F; Deng Y; Li S; Cheng Q; Wang Q; Yu D; Wang Q
    Front Cardiovasc Med; 2023; 10():1108408. PubMed ID: 37206101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac magnetic resonance-feature tracking technique can assess cardiac function and prognosis in patients with myocardial amyloidosis].
    Cui J; Li R; Liu X; Zhao Y; Zhang X; Liu Q; Li T
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):660-666. PubMed ID: 37202205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of admission hyperglycemia on left ventricular stiffness in patients following acute myocardial infarction verified by CMR tissue tracking.
    Han PL; Li K; Jiang Y; Gao Y; Guo YK; Yang ZG; Li Y
    Cardiovasc Diabetol; 2024 Jun; 23(1):210. PubMed ID: 38902730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study.
    Wang J; Li Y; Guo YK; Huang S; Shi R; Yan WF; Qian WL; He GX; Yang ZG
    Cardiovasc Diabetol; 2022 Feb; 21(1):30. PubMed ID: 35193565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of left ventricular systolic and diastolic function in subjects with prediabetes and diabetes using cardiovascular magnetic resonance-feature tracking.
    Zhou S; Zhang Z; Zhang Z; Gao Y; Li G; Lou M; Zhao Z; Zhao J; Li K; Pohost GM
    Acta Diabetol; 2022 Apr; 59(4):491-499. PubMed ID: 34779950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of myocardial scars on left ventricular deformation in type 2 diabetes mellitus after myocardial infarction by contrast-enhanced cardiac magnetic resonance.
    Gao Y; Xu HY; Guo YK; Wen XL; Shi R; Li Y; Yang ZG
    Cardiovasc Diabetol; 2021 Oct; 20(1):215. PubMed ID: 34696783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study.
    Li XM; Yan WF; Shi K; Shi R; Jiang L; Gao Y; Min CY; Liu XJ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Mar; 23(1):90. PubMed ID: 38448890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tissue tracking assessment by cardiovascular magnetic resonance for cardiac amyloidosis and hypertrophic cardiomyopathy.
    Jung HN; Kim SM; Lee JH; Kim Y; Lee SC; Jeon ES; Yong HS; Choe YH
    Acta Radiol; 2020 Jul; 61(7):885-893. PubMed ID: 31684748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global longitudinal diastolic strain rate as a novel marker for predicting adverse outcomes in hypertrophic cardiomyopathy by cardiac magnetic resonance tissue tracking.
    Li ZL; He S; Xia CC; Peng WL; Li L; Liu KL; Zhang JG; Pu J; Guo YK
    Clin Radiol; 2021 Jan; 76(1):78.e19-78.e25. PubMed ID: 32948315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging.
    Shen MT; Li Y; Guo YK; Jiang L; Gao Y; Shi R; Yang ZG
    Cardiovasc Diabetol; 2022 Jun; 21(1):94. PubMed ID: 35659302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Analysis of Myocardial Strain to Wall Thickness Ratio in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy.
    Gannon MP; Sison CP; Saba SG
    J Thorac Imaging; 2024 Jul; 39(4):255-264. PubMed ID: 38193208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-parametric non-contrast cardiac magnetic resonance for the differentiation between cardiac amyloidosis and hypertrophic cardiomyopathy.
    Steen H; Montenbruck M; Kallifatidis A; André F; Frey N; Kelle S; Korosoglou G
    Clin Res Cardiol; 2024 Mar; 113(3):469-480. PubMed ID: 38095711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial and left ventricular strain in feature-tracking cardiac magnetic resonance for predicting patients at high risk of sudden cardiac death in hypertrophic cardiomyopathy.
    Zhu X; Shi Y; Lian J; Shen H; Li L; Wu H; Tian Y; Liu P
    Quant Imaging Med Surg; 2024 May; 14(5):3544-3556. PubMed ID: 38720852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study.
    Li XM; Shi K; Jiang L; Wang J; Yan WF; Gao Y; Shen MT; Shi R; Zhang G; Liu XJ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2024 Jun; 23(1):217. PubMed ID: 38915040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial dysfunction in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy - A comparative three-dimensional speckle-tracking echocardiographic analysis from the MAGYAR-Path Study.
    Földeák D; Kormányos Á; Domsik P; Kalapos A; Piros GÁ; Ambrus N; Ajtay Z; Sepp R; Borbényi Z; Forster T; Nemes A
    Rev Port Cardiol; 2017 Dec; 36(12):905-913. PubMed ID: 29233648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
    Liu S; Li Y; Zhao Y; Wang X; Wu Z; Gu X; Xu B; Li Y; Tian J; Cui J; Wang G; Yu B
    Front Cardiovasc Med; 2022; 9():865615. PubMed ID: 35647085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular myocardial strain quantification with two- and three-dimensional cardiovascular magnetic resonance based tissue tracking.
    Qu YY; Paul J; Li H; Ma GS; Buckert D; Rasche V
    Quant Imaging Med Surg; 2021 Apr; 11(4):1421-1436. PubMed ID: 33816179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.